CA1071632A - Process for the preparation of 4, 5, 6, 7-tetrahydro-thieno (3, 2-c)-pyridine derivatives - Google Patents
Process for the preparation of 4, 5, 6, 7-tetrahydro-thieno (3, 2-c)-pyridine derivativesInfo
- Publication number
- CA1071632A CA1071632A CA249,883A CA249883A CA1071632A CA 1071632 A CA1071632 A CA 1071632A CA 249883 A CA249883 A CA 249883A CA 1071632 A CA1071632 A CA 1071632A
- Authority
- CA
- Canada
- Prior art keywords
- carbon atoms
- alkyl group
- formula
- thieno
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- OGUWOLDNYOTRBO-UHFFFAOYSA-N 4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical class C1NCCC2=C1C=CS2 OGUWOLDNYOTRBO-UHFFFAOYSA-N 0.000 title claims abstract 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 8
- 239000001257 hydrogen Substances 0.000 claims abstract description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 150000002466 imines Chemical class 0.000 claims description 6
- 239000012736 aqueous medium Substances 0.000 claims description 4
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 238000007363 ring formation reaction Methods 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- 230000000146 antalgic effect Effects 0.000 abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 abstract description 4
- 125000005843 halogen group Chemical group 0.000 abstract description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract description 4
- 230000001154 acute effect Effects 0.000 abstract description 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
- 230000001684 chronic effect Effects 0.000 abstract description 2
- 230000002757 inflammatory effect Effects 0.000 abstract description 2
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical group [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 244000171897 Acacia nilotica subsp nilotica Species 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- 101100134298 Bacillus subtilis (strain 168) nucA gene Proteins 0.000 description 1
- 101100009425 Danio rerio dexi gene Proteins 0.000 description 1
- 239000004243 E-number Substances 0.000 description 1
- 235000019227 E-number Nutrition 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101100009427 Mus musculus Dexi gene Proteins 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000193803 Therea Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 210000001872 metatarsal bone Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000793 phophlogistic effect Effects 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7516635A FR2312246A1 (fr) | 1975-05-28 | 1975-05-28 | Derives de la tetrahydro-4,5,6,7 thieno (3,2-c) pyridine, leur procede de preparation et leurs applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1071632A true CA1071632A (en) | 1980-02-12 |
Family
ID=9155775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA249,883A Expired CA1071632A (en) | 1975-05-28 | 1976-04-08 | Process for the preparation of 4, 5, 6, 7-tetrahydro-thieno (3, 2-c)-pyridine derivatives |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US4065460A (OSRAM) |
| JP (1) | JPS5931514B2 (OSRAM) |
| AR (1) | AR209360A1 (OSRAM) |
| AT (1) | AT347949B (OSRAM) |
| BE (1) | BE842249A (OSRAM) |
| CA (1) | CA1071632A (OSRAM) |
| CH (1) | CH596215A5 (OSRAM) |
| DD (1) | DD125215A5 (OSRAM) |
| DE (1) | DE2623566A1 (OSRAM) |
| DK (1) | DK227476A (OSRAM) |
| ES (1) | ES447495A1 (OSRAM) |
| FR (1) | FR2312246A1 (OSRAM) |
| GB (1) | GB1490050A (OSRAM) |
| GR (1) | GR59796B (OSRAM) |
| HU (1) | HU172175B (OSRAM) |
| IE (1) | IE42672B1 (OSRAM) |
| IL (1) | IL49368A0 (OSRAM) |
| LU (1) | LU74573A1 (OSRAM) |
| MX (1) | MX3212E (OSRAM) |
| NL (1) | NL180564C (OSRAM) |
| PH (1) | PH12026A (OSRAM) |
| PL (1) | PL97384B1 (OSRAM) |
| PT (1) | PT65040B (OSRAM) |
| RO (1) | RO69113A (OSRAM) |
| SE (1) | SE421622B (OSRAM) |
| SU (1) | SU604495A3 (OSRAM) |
| YU (1) | YU39612B (OSRAM) |
| ZA (1) | ZA762092B (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4163852A (en) * | 1975-07-09 | 1979-08-07 | Parcor | Process for the preparation of tetrahydro-thieno[3,2-c]- and [2,3-c]pyridine derivatives |
| FR2376860A1 (fr) * | 1977-01-07 | 1978-08-04 | Parcor | Tetrahydro-4,5,6,7 thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application therapeutique |
| FR2397417A1 (fr) * | 1977-07-12 | 1979-02-09 | Parcor | Procede de preparation de derives de la thienopyridine |
| US4419803A (en) * | 1981-02-04 | 1983-12-13 | Ashcombe Products Company | Method of forming a tool assembly |
| CA2682377A1 (en) * | 2007-03-30 | 2008-10-09 | Nippon Shinyaku Co., Ltd. | Heteroaryl derivatives |
| DE102011053619A1 (de) | 2011-09-14 | 2013-03-14 | Becker Marine Systems Gmbh & Co. Kg | Propellerdüse für Wasserfahrzeuge |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2215948B1 (OSRAM) * | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma |
-
1975
- 1975-05-28 FR FR7516635A patent/FR2312246A1/fr active Granted
-
1976
- 1976-03-15 CH CH316276A patent/CH596215A5/xx not_active IP Right Cessation
- 1976-03-16 LU LU74573A patent/LU74573A1/xx unknown
- 1976-03-23 GR GR50383A patent/GR59796B/el unknown
- 1976-04-05 YU YU855/76A patent/YU39612B/xx unknown
- 1976-04-06 IE IE715/76A patent/IE42672B1/en unknown
- 1976-04-06 US US05/674,734 patent/US4065460A/en not_active Expired - Lifetime
- 1976-04-07 ZA ZA762092A patent/ZA762092B/xx unknown
- 1976-04-07 IL IL49368A patent/IL49368A0/xx unknown
- 1976-04-08 CA CA249,883A patent/CA1071632A/en not_active Expired
- 1976-04-27 PT PT65040A patent/PT65040B/pt unknown
- 1976-04-30 ES ES447495A patent/ES447495A1/es not_active Expired
- 1976-05-05 AR AR263207A patent/AR209360A1/es active
- 1976-05-06 NL NLAANVRAGE7604867,A patent/NL180564C/xx not_active IP Right Cessation
- 1976-05-10 SU SU762352255A patent/SU604495A3/ru active
- 1976-05-13 MX MX000232U patent/MX3212E/es unknown
- 1976-05-21 DK DK227476A patent/DK227476A/da unknown
- 1976-05-22 RO RO7686178A patent/RO69113A/ro unknown
- 1976-05-25 AT AT382076A patent/AT347949B/de not_active IP Right Cessation
- 1976-05-25 SE SE7605899A patent/SE421622B/xx not_active IP Right Cessation
- 1976-05-26 BE BE167354A patent/BE842249A/xx not_active IP Right Cessation
- 1976-05-26 DE DE19762623566 patent/DE2623566A1/de not_active Withdrawn
- 1976-05-27 GB GB22087/76A patent/GB1490050A/en not_active Expired
- 1976-05-27 PL PL1976189899A patent/PL97384B1/pl unknown
- 1976-05-27 PH PH18481A patent/PH12026A/en unknown
- 1976-05-28 JP JP51062176A patent/JPS5931514B2/ja not_active Expired
- 1976-05-28 HU HU76PA00001247A patent/HU172175B/hu not_active IP Right Cessation
- 1976-05-28 DD DD193079A patent/DD125215A5/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AT347949B (de) | 1979-01-25 |
| CH596215A5 (OSRAM) | 1978-03-15 |
| ES447495A1 (es) | 1977-07-01 |
| YU39612B (en) | 1985-03-20 |
| DD125215A5 (OSRAM) | 1977-04-06 |
| PL97384B1 (pl) | 1978-02-28 |
| IL49368A0 (en) | 1976-06-30 |
| DK227476A (da) | 1976-11-29 |
| GR59796B (en) | 1978-02-28 |
| SE421622B (sv) | 1982-01-18 |
| ZA762092B (en) | 1977-04-27 |
| LU74573A1 (OSRAM) | 1976-09-01 |
| YU85576A (en) | 1982-05-31 |
| FR2312246B1 (OSRAM) | 1978-08-11 |
| BE842249A (fr) | 1976-11-26 |
| GB1490050A (en) | 1977-10-26 |
| PH12026A (en) | 1978-10-16 |
| FR2312246A1 (fr) | 1976-12-24 |
| HU172175B (hu) | 1978-06-28 |
| IE42672B1 (en) | 1980-09-24 |
| AR209360A1 (es) | 1977-04-15 |
| US4065460A (en) | 1977-12-27 |
| NL180564B (nl) | 1986-10-16 |
| JPS52294A (en) | 1977-01-05 |
| NL180564C (nl) | 1987-03-16 |
| PT65040A (fr) | 1976-05-01 |
| AU1435876A (en) | 1977-12-01 |
| SE7605899L (sv) | 1976-11-29 |
| IE42672L (en) | 1976-11-28 |
| NL7604867A (nl) | 1976-11-30 |
| RO69113A (ro) | 1980-08-15 |
| JPS5931514B2 (ja) | 1984-08-02 |
| PT65040B (fr) | 1977-09-12 |
| MX3212E (es) | 1980-07-17 |
| SU604495A3 (ru) | 1978-04-25 |
| DE2623566A1 (de) | 1976-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4417622B2 (ja) | Ｐａｒｐの阻害剤として用いるためのチエノ［２，３−ｃ］イソキノリン | |
| CA1196330A (en) | Condensed pyrrolinone derivatives, their production and use | |
| US5654309A (en) | Pyridopyrimidine derivatives, their production and use | |
| DE60021262T2 (de) | Bizyklische heteroaromatische verbindungen als lh-agonisten | |
| AU731018B2 (en) | New N-aryl piperidine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| JP7125495B2 (ja) | テトラヒドロイソキノリン化合物、その調製方法、そのような化合物を含む医薬組成物およびその使用 | |
| JP2002513793A (ja) | 新規ｎ−オキシド | |
| KR102420262B1 (ko) | 신규한 퀘르세틴 리독스 유도체 및 bet 억제제로서의 용도 | |
| CA1071632A (en) | Process for the preparation of 4, 5, 6, 7-tetrahydro-thieno (3, 2-c)-pyridine derivatives | |
| KR20100031610A (ko) | 아데노신 Ａ3 수용체 리간드로서의 트리아졸로[1,5-ａ]퀴놀린 | |
| FI76809B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara nya 5-(3-pyridyl)pyrrolo/1,2-c/tiazol-7- karboxamid-derivat. | |
| FI89492C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla tetrahydro-6h-tiazolo/5,4-d/azepiner | |
| JP2021503466A (ja) | 抗ＨＢＶのテトラヒドロイソキサゾロ［４，３−ｃ］ピリジン類化合物 | |
| KR20030053530A (ko) | 인돌 유도체 및 그 의약용도 | |
| KR20000048767A (ko) | Ｎ-(벤조티아졸-2-일)-1-피페리딘에탄아민 유도체, 그의 제법 및치료에의 응용 | |
| US3694450A (en) | 2-substituted-4,5,6,7-tetrahydrobenzothiazole-4-carboxylic acids and their alkyl esters | |
| WO2010045008A1 (en) | AMIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS | |
| KR20250008539A (ko) | 방향족 고리계 화합물 및 이의 용도 | |
| WO2023016249A1 (zh) | 3-芳氧基-3-五元杂芳基-丙胺类化合物的制备方法 | |
| CN118076595A (zh) | 一种五元并六元化合物、制备方法、药物组合物和应用 | |
| JP2024532558A (ja) | チエノ縮合環化合物及びその調製方法と使用 | |
| HRP20020305A2 (en) | 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof | |
| US20080318966A1 (en) | Sinomenine Derivatives and Preparation and Uses Thereof | |
| US3859280A (en) | 2-substituted-4,5,6-tetrahydrobenzothiazole-4-carboxylic acids and their alkyl esters | |
| US3787433A (en) | 2-substituted-4,5,6,7-tetrahydrobenzothiazole-4-carboxylic acids and their alkyl esters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |